Beta Bionics: Speculative Appeal After An Eventful Start To The Year
· the value investor
AI Briefing
- Beta Bionics shares have plunged over two-thirds since December.
- Disappointing 2026 guidance is a major contributor to the decline.
- The company's stock price has taken a significant hit this year.
Advertisement